OptimizeRx Corp OPRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
-
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
-
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
-
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
-
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
-
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
-
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
Trading Information
- Previous Close Price
- $9.08
- Day Range
- $8.89–9.31
- 52-Week Range
- $4.54–22.25
- Bid/Ask
- $9.11 / $9.15
- Shares Outstanding
- 18.84M
- Market Cap
- $172.35M
- Volume/Avg
- 77,098 / 190,063
Key Statistics
- Price/Earnings (Normalized)
- 14.10
- Price/Sales
- 1.76
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 105
- Website
- https://www.optimizerx.com
Valuation
|
Metric
|
OPRX
|
|---|---|
Price/Earnings (Normalized) | 14.10 |
Price/Book Value | 1.30 |
Price/Sales | 1.76 |
Price/Cash Flow | 9.47 |
Price/Earnings
OPRX
Financial Strength
|
Metric
|
OPRX
|
|---|---|
Quick Ratio | 5.27 |
Current Ratio | 5.58 |
Interest Coverage | 2.38 |
Quick Ratio
OPRX
Profitability
|
Metric
|
OPRX
|
|---|---|
Return on Assets (Normalized) | 11.08% |
Return on Equity (Normalized) | 14.90% |
Return on Invested Capital (Normalized) | 14.35% |
Return on Assets
OPRX
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|@??cRV> | LOCK|D%w | $52B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|qjB<# | $14B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|^P&^v | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|wr><! | $12B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|V<! | $12B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|$#dC | $9B | |||
| HealthEquity Inc
HQY
| — | LOCK|PZ&@ | $8B | |||
| M3 Inc
MTHRF
| — | LOCK|t?wd | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|llFh | $8B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|># | $6B |
United States